Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: A randomized clinical study

Journal of Dermatological Treatment

Volumn 20, Issue 6, 2009, Pages 344-349

  Cicek, Demet ^a   Kandi, Basak ^a   Bakar, Selma ^a   Turgut, Dilara ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Methylprednisolone aceponate; Metronidazole; Pimecrolimus; Seborrhoeic dermatitis

Indexed keywords

METHYLPREDNISOLONE ACEPONATE; METRONIDAZOLE; PIMECROLIMUS;

ABNORMAL SENSATION; ADOLESCENT; ADULT; APPLICATION SITE BURNING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHEMA; FACE; FEMALE; GEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRICKLING SENSATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEBORRHEIC DERMATITIS; SKIN EDEMA; SKIN PRURITUS;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DERMATITIS, SEBORRHEIC; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; EMOLLIENTS; FACE; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; METRONIDAZOLE; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX; TACROLIMUS; TREATMENT OUTCOME;

EID: 72449200210     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546630802687349     Document Type: Article

References (21)

1. Braun-Falco O, Plewing G, Wolff HH, Burgdorf WH Jr. Dermatitis. In: Braun-Falco O, Plewing G, Wolff HH, Burgdorf WH Jr, editors. Dermatology. 2nd ed. Berlin: Springer-Verlag; 2000. p. 457-520.
2. Odom RB, James WD, Berger TG. Seborrheic dermatitis, psoriasis recalcitrant palmoplantar eruptions, pustular dermatitis, and erythroderma. In: Odom RB, James WD, Berger TG, editors. Andrews' diseases of the skin. 9th ed. Philadelphia: WB Saunders; 2000. p. 214-253
3. Gupta AK, Chow M. Pimecrolimus: A review. J Eur Acad DermatolVenereol. 2003;17:493-503.
4. Miyachi Y, Imamura S, Niwa Y. Anti-oxidant action of metronidazole: A possible mechanism of action in rosacea. Br J Dermatol. 1986;114:231-4. (Pubitemid 16131430)
5. Aizawa H, Michihito N, KonY Influence of oral metronidazole on the endocrine milieu and sebum excretion rate. J Dermatol. 1992;9:959-963
6. Nielsen PG. In vitro antifungal effect of metronidazole on Pityrosporum ovale. Mykosen. 1984;27:474-476
7. Koca R, Altinyazar HC, Eştürk E. Is topical metronidazole effective in seborrhoeic dermatitis? A double-blind study. Int J Dermatol. 2003;42:632-635
8. Ozcan H, Seyhan M, Yologlu S. Is metronidazole 0.75% gel effective in the treatment of seborrhoeic dermatitis? A double-blind, placebo controlled study. Eur J Dermatol. 2007;17:313-316
9. Parsad D, Pandhi R, Negi KS, Kumar B. Topical metronidazole in seborrhoeic dermatitis-a double-blind study. Dermatology. 2001;202:35-37
10. Seckin D, Gurbuz O, Akin O. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrhoeic dermatitis: A randomized, double-blind study. J Eur Acad Dermatol Venereol. 2007;21:345-350
11. Grassberger M, Steinhoff M, Schneider D, Luger TA. Pimecrolimus-An anti-inflammatory drug targeting the skin. Exp Dermatol. 2004;13:721-730
12. Luger T, VanLeent EJM, Graeber M, Hedgecock S, Thurston M, Kandra A, et al. SDZ ASM 981: An emerging safe and effective treatment of atopic dermatitis. Br J Dermatol. 2001;144:788-794
13. Brownell I, Quan LT, Hsu S. Topical pimecrolimus in the treatment of seborrheic dermatitis. Dermatol Online J. 2003;9:13.
14. Kim BS, Kim SH, Kim MB, Oh CK, Jang HS, Kwon KS. Treatment of facial seborrheic dermatitis with pimecrolimus cream 1%: An open-label clinical study in Korean patients. J Korean Med Sci. 2007;22:868-872
15. Rallis E, Nasiopoulou A, Kouskoukis C, Koumantaki E. Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk. Drugs Exp Clin Res. 2004;30:191-195
16. Cunha PR. Pimecrolimus cream 1% is effective in seborrhoeic dermatitis refractory to treatment with topical corticosteroids. Acta Derm Venereol. 2006;6:69-70.
17. Warshaw EM, Wohlhuter RJ, Liu A, Zeller SA, Wenner RA, Bowers S, et al. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. J Am Acad Dermatol. 2007;57:257-264
18. Koc E, Area E, Kose O, Akar A. An open, randomized, prospective, comparative study of topical pimecrolimus 1 % cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. J DermatologTreat. 2008;1:1-5.
19. Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. Br J Dermatol. 2004;151:1071-1075
20. Gorman CR, White SW. Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream. Arch Dermatol. 2004;140:457-460
21. Ehst BD, Warshaw EM. Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin. Arch Dermatol. 2004;140:1014-1015